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Mass Spectrometry
Group Has Mass
Appeal
The field of proteomics seeks to define, on
a global scale, the levels, activities, regula-
tion, and interaction of proteins in a bio-
logical sample. Proteomics is analogous to
transcriptomics—the global analysis of
mRNA transcripts that arise from the
expression of genes in the genome—
although the former is considerably more
complicated. Whereas the human genome
comprises approximately 30,000 genes,
there are likely over 100,000 unique pro-
teins in the human proteome due to the
multiple ways each gene can be transcribed
and translated into proteins by cellular
machinery. 
Because proteins are fundamental com-
ponents of all living cells, including
enzymes, hormones, and antibodies, they
are constantly in flux as the body takes in
food, metabolizes it, and stores or burns
energy. Furthermore, different proteins are
produced and expressed at different devel-
opmental stages of an organism’s life cycle,
from the moment of conception through-
out the aging process. Consequently, pro-
teomics is a dynamic, challenging research
area. One of the essential tools being used
to meet this challenge is mass spectrometry
(MS), which is the focal point of
the National Center for Toxico-
genomics (NCT) Mass Spec-
trometry Group.
There are a large number of
proteins in a system at any one
time, and they are always chang-
ing as an organism eats and
metabolizes food, exercises, and
sleeps. The proteome—all the
proteins expressed in a living sys-
tem—is therefore unique to the
cell or tissue under study. The
more narrowly one can define
where the proteins are localized within the
system (such as in a specific tissue or loca-
tion in a cell), the easier it is to characterize
the specific proteins and quantify their
varying levels of expression.
Proteomics research at the NCT focus-
es largely on changes in an organism’s pro-
teome in response to an event such as expo-
sure to an environmental toxicant, in order
to advance understanding of how people
might respond to chemical exposures in
their environment. The Mass Spectrometry
Group, led by NIEHS principal investiga-
tor Kenneth B. Tomer, employs high-
throughput techniques, including MS, to
examine hundreds or thousands of protein
changes in a large number of samples.
Because proteomics techniques produce
large amounts of data, sophisticated analy-
sis tools are used to decipher the results and
identify key changes in select protein bio-
markers that convey valuable information
about exposure to harmful chemicals. The
MS facility performs analyses for the intra-
mural NIEHS research community, and
Tomer also conducts his own collaborative
research projects as part of the NCT
Proteomics Group.
Critical Mass
MS enables identification of the composi-
tion of a compound based on its mass-to-
charge ratio. A sample is ionized, and the
charged molecular particles are propelled
through an electromagnetic or electric field
for separation by differences in mass (mole-
cular weight). A detector records the abun-
dance and mass information for each
charged mass and produces a pattern called
a mass spectrum. The composition of the
sample can be determined based on the
mass and relative abundances of ions. 
The proteins coming from a specific tis-
sue, cell, or cellular component are separat-
ed before they are identified using MS.
Separation can be done simply at the
whole-protein level using two-dimensional
gel electrophoresis; this technique separates
molecules by molecular weight and isoelec-
tric point (the pH at which a molecule car-
ries no net electrical charge). The proteins
are visualized with various dyes as bands or
spots on the gel. The proteins can be more
easily identified after the band or spot is cut
out, at which point they are digested with
enzymes (typically the pancreatic enzyme
trypsin) into smaller peptides. 
The resulting peptides are identified by
“mass fingerprinting,” in which masses of
the individual peptides from a gel band are
compared with peptide sequences included
in the National Center for Biotechnology
Information protein database (http://ncbi.
nlm.nih.gov/). There are publicly available
search engines that can match the mass fin-
gerprint against this database for over
1,000 different types of organisms. The
search produces a list of possible proteins
that might match the mass fingerprint and
gives a probability score. 
A high probability score indicates a
good match between the unknown peptide
sequence and a sequence in the database.
The lower the score, the less likely it is that
the unknown protein matches peptides in
the database. For example, if 10 peptides
can be identified in a sample and all 10
have a high probability for match accura-
cy with a particular protein in the data-
base, then there is high confidence that
the identification is accurate. However, if
the match probabilities are low, the iden-
tification cannot be made with any degree
of certainty.
A researcher can then go a step further
toward identifying the unknown peptides
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Keeping an eye on ions. After proteins are separated,
they are digested into peptides and deposited on a plate
(left), which is then inserted into the mass spectrometer
(above). Analysis provides information on the ionized sam-
ple’s molecular weight and chemical structure.by using an instrument known as a tandem
MS to obtain sequence information on their
constituent amino acids. This information
complements mass assignment and
improves identification reliability. This pro-
cedure involves digestion of an entire sam-
ple with trypsin, followed by separation of
the peptides with a high-performance liquid
chromatograph and then identification with
sequential MS steps. At the second step of
MS, the peptide ion is fragmented into
smaller amino acids to obtain the mass and
sequence information. When sequence
information for amino acids correlates well
with mass assignment, there is a stronger
case for the identity of the protein. Because
the result is a probability, additional separa-
tion and identification techniques such as
antibody arrays and/or Western blotting are
employed to provide backup
data to corroborate important
identifications.
Cracking a Tough Nut
A particularly challenging
area of study within pro-
teomics is post-translational
modification of proteins.
Post-translational modifica-
tion is a process by which
proteins undergo specific
structural changes at certain
sites that impart special func-
tions to the protein. The cel-
lular processes involved in
post-translational modifica-
tions are highly dynamic
and very localized, such that
modifications can be added
or removed very rapidly to a
small portion of each pro-
tein population as the cell
requires. The transient, local-
ized, and proportional nature
of post-translational processes
makes it difficult to detect
this special subset of molecules. For exam-
ple, says Tomer, phosphorylation is a fre-
quent post-translational modification
involved in cell signaling, but even during
active signaling, phosphorylation may
occur at only one spot on a protein and
upon less than 5% of that particular pro-
tein population for less than one minute.
Yet this type of tiny, rapid modification is
vital to cellular function—and crucial to
our understanding of toxicity.
Tomer and NCT Proteomics Group
toxicologist Alex Merrick addressed the
phosphorylation question directly in a
model system designed to increase their
chances of finding phosphorylations on p53,
a key protein controlling cell growth and
death. In research published 3 April 2001 in
Biochemistry, they separated p53 from the
proteome of an expression line of Sf9 insect
cells in which some cells had been exposed
to okadaic acid, a natural phosphatase
inhibitor produced by marine algae.
Phosphatase inhibition by okadaic acid
results in an overall increase in protein phos-
phorylation and an imbalance in cell signal-
ing that leads to toxicity. 
Using MS, Tomer, Merrick, and col-
leagues identified a number of amino acid
sites on the p53 protein that were phospho-
rylated, and they further discovered that
okadaic acid completely phosphorylated
one particular site on p53 (serine 315).
They speculate that phosphorylation at that
site may have particular biological signifi-
cance for p53, and that studying these
processes could improve understanding of
the health consequences resulting from
phosphorylation of proteins through expo-
sure to environmental contaminants. 
The Power of Comparison
Merrick points to protein profiling as an
important use of proteomics in toxicology
(toxicoproteomics). Protein profiling, he
says, allows a “differential quantification of
proteins in one sample that are compared
with another sample to see the differences
in protein expression.” Comparison of pro-
tein differences after exposure to toxicants
is one way to find out which proteins
respond to the chemicals. Sometimes, these
changed proteins lead to unexpected dis-
coveries during the course of toxico-
proteomics studies. 
For example, it is well recognized that
dioxin has major effects on the immune sys-
tem, but how dioxin mediates these effects
is still a mystery as the exact biochemical
targets have not been identified. A collabo-
rative study between Tomer, Merrick, and
Nigel Walker of the National Toxicology
Program, published 15 October 2002 in
Archives of Biochemistry and Biophysics, led
to the discovery of immune-responsive
proteins in the endoplasmic reticulum, a
region of the cell where they had not
been observed before. This is an example
of how, in addition to identifying pro-
teins involved in toxicity, proteomics
research can be extended into discovery
of specific areas within the cell where a
toxic action occurs.
The NCT Mass Spectrometry and
Proteomics groups, in con-
cert with the NIEHS Micro-
array Center, are currently
investigating the toxicity of
acetaminophen. Although
acetaminophen is normally a
safe and effective analgesic
when used in accordance
with the manufacturer’s
instructions, cases of over-
dose or patient susceptibility
do occur, and are cause for
emergency room visits and
concern to public health.
Certain populations such as
small children, older adults
with compromised liver func-
tion, and substance abusers
are more susceptible to over-
dose complications. By using
discovery genomics and pro-
teomics technologies to profile
gene and protein expression in
experimental animals, NCT
scientists hope to use MS and
other technologies to identify
biomarkers in the liver and
blood that will be informative about the
degree of toxicity and prognosis for survival
and recovery.
Advances in MS techniques for pro-
teome analysis have made this tool an
excellent choice for the identification and
quantification of proteins and post-transla-
tional modification of proteins, with a
high level of specificity and sensitivity.
Through collaborative research on a variety
of intramural projects, NCT researchers
are employing MS to shed light on how
protein expression and protein–protein
interactions are affected by exposure to dif-
ferent environmental toxicants, and are
making progress toward development of
protein biomarkers that can be used for
diagnosing exposure. –Mary Eubanks
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Peak power. Spectra like this protein signature generated during acetaminophen
studies at the NCT/NIEHS offer clues about the potential toxicity of drugs.